Arrowhead Pharmaceuticals, Inc.
ARWR
$17.67
$0.321.84%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -5.70% | 5.58% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.05% | -7.91% | |||
| Operating Income | 0.49% | 7.91% | |||
| Income Before Tax | -1.34% | 0.68% | |||
| Income Tax Expenses | -81.14% | -- | |||
| Earnings from Continuing Operations | -1.08% | 0.36% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -24.04% | -11.81% | |||
| Net Income | -1.49% | 0.15% | |||
| EBIT | 0.49% | 7.91% | |||
| EBITDA | 0.64% | 8.28% | |||
| EPS Basic | -1.09% | 0.28% | |||
| Normalized Basic EPS | -1.62% | 0.47% | |||
| EPS Diluted | -1.36% | 0.62% | |||
| Normalized Diluted EPS | -1.62% | 0.47% | |||
| Average Basic Shares Outstanding | 0.40% | 0.13% | |||
| Average Diluted Shares Outstanding | 0.40% | 0.13% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
